Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BMEA |
---|---|---|
09:32 ET | 13450 | 10.035 |
09:34 ET | 400 | 10.035 |
09:36 ET | 1894 | 9.93 |
09:38 ET | 1430 | 9.94 |
09:39 ET | 1800 | 9.96 |
09:41 ET | 1294 | 9.8936 |
09:43 ET | 1250 | 9.88 |
09:45 ET | 3637 | 9.9286 |
09:48 ET | 2300 | 9.85 |
09:50 ET | 1286 | 9.86 |
09:52 ET | 3960 | 9.86 |
09:54 ET | 600 | 9.92 |
09:56 ET | 7926 | 9.93 |
09:57 ET | 658 | 9.955 |
09:59 ET | 600 | 9.965 |
10:01 ET | 7691 | 9.97 |
10:03 ET | 300 | 9.9423 |
10:06 ET | 1033 | 9.87 |
10:08 ET | 1341 | 9.93 |
10:10 ET | 7300 | 9.9246 |
10:12 ET | 1653 | 9.91 |
10:15 ET | 1299 | 9.88 |
10:17 ET | 10399 | 9.719 |
10:19 ET | 5230 | 9.695 |
10:21 ET | 9350 | 9.59 |
10:24 ET | 25733 | 9.65 |
10:26 ET | 11599 | 9.7878 |
10:28 ET | 1180 | 9.72 |
10:30 ET | 11843 | 9.6 |
10:32 ET | 2276 | 9.59 |
10:33 ET | 1411 | 9.57 |
10:35 ET | 3324 | 9.54 |
10:37 ET | 4714 | 9.5 |
10:39 ET | 1904 | 9.54 |
10:42 ET | 12471 | 9.39 |
10:44 ET | 3250 | 9.32 |
10:46 ET | 9985 | 9.28 |
10:48 ET | 8228 | 9.2801 |
10:50 ET | 812 | 9.31 |
10:51 ET | 2889 | 9.4466 |
10:53 ET | 2108 | 9.41 |
10:55 ET | 3754 | 9.45 |
10:57 ET | 104962 | 9.24 |
11:00 ET | 6206 | 9.3 |
11:02 ET | 2691 | 9.31 |
11:04 ET | 5548 | 9.33 |
11:06 ET | 3423 | 9.2934 |
11:08 ET | 2410 | 9.28 |
11:09 ET | 4943 | 9.155 |
11:11 ET | 2079 | 9.29 |
11:13 ET | 3026 | 9.2899 |
11:15 ET | 2484 | 9.245 |
11:18 ET | 3533 | 9.225 |
11:20 ET | 3038 | 9.23 |
11:22 ET | 900 | 9.26 |
11:24 ET | 1900 | 9.256 |
11:26 ET | 506 | 9.245 |
11:27 ET | 24760 | 9.27 |
11:29 ET | 3298 | 9.3803 |
11:31 ET | 5307 | 9.4078 |
11:33 ET | 317 | 9.43 |
11:36 ET | 1265 | 9.42 |
11:38 ET | 2849 | 9.4423 |
11:40 ET | 1612 | 9.44 |
11:42 ET | 900 | 9.44 |
11:44 ET | 400 | 9.4424 |
11:45 ET | 11200 | 9.5 |
11:47 ET | 300 | 9.54 |
11:49 ET | 5900 | 9.54 |
11:51 ET | 227 | 9.5565 |
11:54 ET | 1823 | 9.555 |
11:56 ET | 4400 | 9.5199 |
11:58 ET | 1350 | 9.51 |
12:00 ET | 981 | 9.5 |
12:02 ET | 1491 | 9.53 |
12:03 ET | 4948 | 9.53 |
12:05 ET | 1800 | 9.515 |
12:07 ET | 2256 | 9.525 |
12:09 ET | 2402 | 9.3834 |
12:16 ET | 700 | 9.46 |
12:18 ET | 1002 | 9.46 |
12:20 ET | 750 | 9.49 |
12:21 ET | 500 | 9.47 |
12:25 ET | 1350 | 9.53 |
12:27 ET | 630 | 9.55 |
12:30 ET | 450 | 9.55 |
12:34 ET | 200 | 9.54 |
12:36 ET | 2240 | 9.51 |
12:38 ET | 1064 | 9.51 |
12:41 ET | 1436 | 9.505 |
12:43 ET | 1579 | 9.485 |
12:45 ET | 100 | 9.4881 |
12:48 ET | 1046 | 9.47 |
12:50 ET | 600 | 9.49 |
12:52 ET | 2466 | 9.49 |
12:54 ET | 100 | 9.5 |
12:56 ET | 974 | 9.55 |
12:59 ET | 100 | 9.57 |
01:01 ET | 450 | 9.565 |
01:03 ET | 2539 | 9.515 |
01:06 ET | 1485 | 9.4252 |
01:08 ET | 405 | 9.4997 |
01:10 ET | 105 | 9.4201 |
01:12 ET | 709 | 9.52 |
01:14 ET | 1421 | 9.44 |
01:15 ET | 1200 | 9.45 |
01:17 ET | 2191 | 9.35 |
01:19 ET | 1000 | 9.375 |
01:21 ET | 3163 | 9.325 |
01:24 ET | 8790 | 9.2592 |
01:26 ET | 2303 | 9.325 |
01:28 ET | 143 | 9.33 |
01:30 ET | 550 | 9.34 |
01:32 ET | 3173 | 9.365 |
01:33 ET | 2018 | 9.31 |
01:35 ET | 900 | 9.3628 |
01:37 ET | 750 | 9.36 |
01:39 ET | 200 | 9.36 |
01:42 ET | 771 | 9.3525 |
01:44 ET | 1454 | 9.33 |
01:46 ET | 5193 | 9.34 |
01:48 ET | 1410 | 9.33 |
01:50 ET | 865 | 9.35 |
01:51 ET | 300 | 9.36 |
01:53 ET | 3153 | 9.315 |
01:55 ET | 1015 | 9.315 |
01:57 ET | 540 | 9.315 |
02:00 ET | 3260 | 9.3 |
02:02 ET | 1085 | 9.3 |
02:04 ET | 3779 | 9.29 |
02:06 ET | 1986 | 9.3 |
02:08 ET | 200 | 9.28 |
02:09 ET | 5100 | 9.24 |
02:11 ET | 9213 | 9.185 |
02:13 ET | 3545 | 9.215 |
02:15 ET | 2500 | 9.2699 |
02:18 ET | 1475 | 9.255 |
02:20 ET | 705 | 9.25 |
02:22 ET | 726 | 9.3 |
02:24 ET | 11058 | 9.3688 |
02:26 ET | 2028 | 9.37 |
02:27 ET | 1554 | 9.45 |
02:29 ET | 269 | 9.48 |
02:31 ET | 200 | 9.48 |
02:33 ET | 4643 | 9.515 |
02:36 ET | 5599 | 9.46 |
02:38 ET | 200 | 9.45 |
02:40 ET | 1100 | 9.41 |
02:42 ET | 729 | 9.4 |
02:44 ET | 1500 | 9.455 |
02:45 ET | 3881 | 9.52 |
02:47 ET | 400 | 9.4799 |
02:49 ET | 600 | 9.46 |
02:51 ET | 3266 | 9.44 |
02:54 ET | 1000 | 9.41 |
02:56 ET | 2815 | 9.44 |
02:58 ET | 165 | 9.43 |
03:00 ET | 1470 | 9.44 |
03:02 ET | 4605 | 9.44 |
03:03 ET | 300 | 9.435 |
03:05 ET | 8940 | 9.43 |
03:07 ET | 300 | 9.42 |
03:09 ET | 1728 | 9.455 |
03:12 ET | 5677 | 9.45 |
03:14 ET | 100 | 9.435 |
03:16 ET | 2990 | 9.48 |
03:21 ET | 200 | 9.49 |
03:25 ET | 450 | 9.485 |
03:27 ET | 4370 | 9.51 |
03:30 ET | 5153 | 9.58 |
03:32 ET | 2266 | 9.6 |
03:34 ET | 1451 | 9.65 |
03:36 ET | 800 | 9.67 |
03:38 ET | 5274 | 9.58 |
03:39 ET | 23057 | 9.5305 |
03:41 ET | 3569 | 9.51 |
03:43 ET | 1510 | 9.56 |
03:45 ET | 369 | 9.54 |
03:48 ET | 300 | 9.54 |
03:50 ET | 3972 | 9.58 |
03:52 ET | 5494 | 9.57 |
03:54 ET | 4873 | 9.51 |
03:56 ET | 8301 | 9.49 |
03:57 ET | 3483 | 9.481 |
03:59 ET | 54179 | 9.5 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Biomea Fusion Inc | 365.7M | -2.4x | --- |
Nautilus Biotechnology Inc | 357.4M | -4.8x | --- |
Lyell Immunopharma Inc | 353.3M | -1.5x | --- |
GH Research PLC | 348.1M | 0.0x | --- |
Eliem Therapeutics Inc | 341.3M | -2.4x | --- |
Corvus Pharmaceuticals Inc | 330.3M | -11.4x | --- |
Biomea Fusion, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of oral covalent small molecules to treat patients with metabolic diseases and genetically defined cancers. A covalent small molecule is a synthetic compound that forms a permanent bond to its target protein. The Company is utilizing its proprietary FUSION System to discover, design and develop a pipeline of covalent-binding small molecule medicines designed to maximize clinical benefit for patients. Its lead product candidate, BMF-219, is designed to be an oral, potent, and selective covalent inhibitor of menin, built from its FUSION System. It is developing BMF-219 for the treatment of menin regulated or dependent diseases, such as type 1 and type 2 diabetes as well as subtypes of liquid and solid tumors. Its second development candidate, BMF-500, a covalent inhibitor of activating mutations of the FMS-like tyrosine kinase 3 (FLT3).
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $365.7M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 36.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.45 |
EPS | $-3.90 |
Book Value | $4.72 |
P/E Ratio | -2.4x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.